{"id":"https://openalex.org/W7220739600","doi":"https://doi.org/10.3389/fcimb.2026.1955105","title":"An intravaginal ring for HIV pre-exposure prophylaxis: assessment of safety and pharmacokinetics in a randomized, placebo-controlled clinical trial","display_name":"An intravaginal ring for HIV pre-exposure prophylaxis: assessment of safety and pharmacokinetics in a randomized, placebo-controlled clinical trial","publication_year":2026,"publication_date":"2026-10-06","ids":{"openalex":"https://openalex.org/W7220739600","doi":"https://doi.org/10.3389/fcimb.2026.1955105","pmid":"https://pubmed.ncbi.nlm.nih.gov/42903070","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13680163"},"language":"en","primary_location":{"id":"doi:10.3389/fcimb.2026.1955105","doi":"https://doi.org/10.3389/fcimb.2026.1955105","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fcimb.2026.1955105","pdf_url":"https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2026.1955105/pdf","source":{"id":"https://openalex.org/S2506667490","display_name":"Frontiers in Cellular and Infection Microbiology","issn_l":"2235-2988","issn":["2235-2988"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Cellular and Infection Microbiology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2026.1955105/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027079293","display_name":"Kathleen L. Vincent","orcid":"https://orcid.org/0000-0003-3051-9551","observed_orcids":["https://orcid.org/0000-0003-3051-9551"]},"institutions":[{"id":"https://openalex.org/I55302922","display_name":"The University of Texas Medical Branch at Galveston","ror":"https://ror.org/016tfm930","country_code":"US","type":"education","lineage":["https://openalex.org/I55302922"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kathleen L. Vincent","raw_affiliation_strings":["Department of Obstetrics and Gynecology, University of Texas Medical Branch"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, University of Texas Medical Branch","institution_ids":["https://openalex.org/I55302922"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000453333","display_name":"John A. Moss","orcid":"https://orcid.org/0000-0001-8091-3245","observed_orcids":["https://orcid.org/0000-0001-8091-3245"]},"institutions":[{"id":"https://openalex.org/I4210086937","display_name":"Oak Crest Institute of Science","ror":"https://ror.org/0006n3612","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210086937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John A. Moss","raw_affiliation_strings":["Department of Chemistry, Oak Crest Institute of Science"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Oak Crest Institute of Science","institution_ids":["https://openalex.org/I4210086937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082007029","display_name":"Mark A. Marzinke","orcid":"https://orcid.org/0000-0003-1670-8786","observed_orcids":["https://orcid.org/0000-0003-1670-8786"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark A. Marzinke","raw_affiliation_strings":["Department of Pathology, Johns Hopkins University","Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Johns Hopkins University","institution_ids":["https://openalex.org/I145311948"]},{"raw_affiliation_string":"Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077662103","display_name":"Richard B. Pyles","orcid":"https://orcid.org/0000-0002-2215-5500","observed_orcids":["https://orcid.org/0000-0002-2215-5500"]},"institutions":[{"id":"https://openalex.org/I55302922","display_name":"The University of Texas Medical Branch at Galveston","ror":"https://ror.org/016tfm930","country_code":"US","type":"education","lineage":["https://openalex.org/I55302922"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard B. Pyles","raw_affiliation_strings":["Department of Microbiology and Immunology, University of Texas Medical Branch","Department of Pediatrics, University of Texas Medical Branch"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology and Immunology, University of Texas Medical Branch","institution_ids":["https://openalex.org/I55302922"]},{"raw_affiliation_string":"Department of Pediatrics, University of Texas Medical Branch","institution_ids":["https://openalex.org/I55302922"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5135770153","display_name":"Lauren Dawson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55302922","display_name":"The University of Texas Medical Branch at Galveston","ror":"https://ror.org/016tfm930","country_code":"US","type":"education","lineage":["https://openalex.org/I55302922"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lauren Dawson","raw_affiliation_strings":["Department of Obstetrics and Gynecology, University of Texas Medical Branch"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, University of Texas Medical Branch","institution_ids":["https://openalex.org/I55302922"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108629190","display_name":"Trevelyn J. Olive","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55302922","display_name":"The University of Texas Medical Branch at Galveston","ror":"https://ror.org/016tfm930","country_code":"US","type":"education","lineage":["https://openalex.org/I55302922"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Trevelyn J. Olive","raw_affiliation_strings":["Department of Obstetrics and Gynecology, University of Texas Medical Branch"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, University of Texas Medical Branch","institution_ids":["https://openalex.org/I55302922"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028920905","display_name":"Irina Butkyavichene","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086937","display_name":"Oak Crest Institute of Science","ror":"https://ror.org/0006n3612","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210086937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Irina Butkyavichene","raw_affiliation_strings":["Department of Chemistry, Oak Crest Institute of Science"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Oak Crest Institute of Science","institution_ids":["https://openalex.org/I4210086937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056241558","display_name":"Amalia E. Castonguay","orcid":"https://orcid.org/0000-0002-6358-1784","observed_orcids":["https://orcid.org/0000-0002-6358-1784"]},"institutions":[{"id":"https://openalex.org/I4210086937","display_name":"Oak Crest Institute of Science","ror":"https://ror.org/0006n3612","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210086937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amalia E. Castonguay","raw_affiliation_strings":["Department of Chemistry, Oak Crest Institute of Science"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Oak Crest Institute of Science","institution_ids":["https://openalex.org/I4210086937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043315321","display_name":"John M. Cortez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086937","display_name":"Oak Crest Institute of Science","ror":"https://ror.org/0006n3612","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210086937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John M. Cortez","raw_affiliation_strings":["Department of Chemistry, Oak Crest Institute of Science"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Oak Crest Institute of Science","institution_ids":["https://openalex.org/I4210086937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075507401","display_name":"Mariana Remedios-Chan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086937","display_name":"Oak Crest Institute of Science","ror":"https://ror.org/0006n3612","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210086937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mariana Remedios-Chan","raw_affiliation_strings":["Department of Chemistry, Oak Crest Institute of Science"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Oak Crest Institute of Science","institution_ids":["https://openalex.org/I4210086937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059201728","display_name":"Patricia Galv\u00e1n","orcid":"https://orcid.org/0000-0002-8153-0307","observed_orcids":["https://orcid.org/0000-0002-8153-0307"]},"institutions":[{"id":"https://openalex.org/I4210086937","display_name":"Oak Crest Institute of Science","ror":"https://ror.org/0006n3612","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210086937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patricia Galvan","raw_affiliation_strings":["Department of Chemistry, Oak Crest Institute of Science"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Oak Crest Institute of Science","institution_ids":["https://openalex.org/I4210086937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157759874","display_name":"Sofia Rivera","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086937","display_name":"Oak Crest Institute of Science","ror":"https://ror.org/0006n3612","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210086937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sofia Rivera","raw_affiliation_strings":["Department of Chemistry, Oak Crest Institute of Science"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Oak Crest Institute of Science","institution_ids":["https://openalex.org/I4210086937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157743125","display_name":"Simon Webster","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086937","display_name":"Oak Crest Institute of Science","ror":"https://ror.org/0006n3612","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210086937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Simon Webster","raw_affiliation_strings":["Department of Chemistry, Oak Crest Institute of Science"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Oak Crest Institute of Science","institution_ids":["https://openalex.org/I4210086937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075413650","display_name":"Manjula Gunawardana","orcid":"https://orcid.org/0000-0002-3137-8669","observed_orcids":["https://orcid.org/0000-0002-3137-8669"]},"institutions":[{"id":"https://openalex.org/I4210086937","display_name":"Oak Crest Institute of Science","ror":"https://ror.org/0006n3612","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210086937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manjula Gunawardana","raw_affiliation_strings":["Department of Chemistry, Oak Crest Institute of Science"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Oak Crest Institute of Science","institution_ids":["https://openalex.org/I4210086937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037545171","display_name":"Amy P. Adler","orcid":"https://orcid.org/0000-0002-1854-6613","observed_orcids":["https://orcid.org/0000-0002-1854-6613"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amy P. Adler","raw_affiliation_strings":["Jumpstart Research Consulting, LLC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jumpstart Research Consulting, LLC","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022088425","display_name":"Christina M. Ramirez","orcid":"https://orcid.org/0000-0002-8435-0416","observed_orcids":["https://orcid.org/0000-0002-8435-0416"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christina M. Ramirez","raw_affiliation_strings":["Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles (UCLA)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles (UCLA)","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028131735","display_name":"Hans M. L. Spiegel","orcid":"https://orcid.org/0000-0001-9552-789X","observed_orcids":["https://orcid.org/0000-0001-9552-789X"]},"institutions":[{"id":"https://openalex.org/I4210134534","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hans M. L. Spiegel","raw_affiliation_strings":["Kelly Government Solutions, Contractor to Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kelly Government Solutions, Contractor to Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health","institution_ids":["https://openalex.org/I4210134534"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053567182","display_name":"Craig W. Hendrix","orcid":"https://orcid.org/0000-0002-5696-8665","observed_orcids":["https://orcid.org/0000-0002-5696-8665"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210086937","display_name":"Oak Crest Institute of Science","ror":"https://ror.org/0006n3612","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210086937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Craig W. Hendrix","raw_affiliation_strings":["Department of Chemistry, Oak Crest Institute of Science","Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Oak Crest Institute of Science","institution_ids":["https://openalex.org/I4210086937"]},{"raw_affiliation_string":"Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054402928","display_name":"Peter A. Anton","orcid":"https://orcid.org/0000-0002-4677-6782","observed_orcids":["https://orcid.org/0000-0002-4677-6782"]},"institutions":[{"id":"https://openalex.org/I4210086937","display_name":"Oak Crest Institute of Science","ror":"https://ror.org/0006n3612","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210086937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter A. Anton","raw_affiliation_strings":["Department of Chemistry, Oak Crest Institute of Science"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Oak Crest Institute of Science","institution_ids":["https://openalex.org/I4210086937"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086096371","display_name":"Marc M. Baum","orcid":"https://orcid.org/0000-0003-1558-5649","observed_orcids":["https://orcid.org/0000-0003-1558-5649"]},"institutions":[{"id":"https://openalex.org/I4210086937","display_name":"Oak Crest Institute of Science","ror":"https://ror.org/0006n3612","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210086937"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Marc M. Baum","raw_affiliation_strings":["Department of Chemistry, Oak Crest Institute of Science"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Oak Crest Institute of Science","institution_ids":["https://openalex.org/I4210086937"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5027079293","https://openalex.org/A5086096371"],"corresponding_institution_ids":["https://openalex.org/I4210086937","https://openalex.org/I55302922"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.75601191,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":null,"first_page":"1955105","last_page":"1955105"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.9487000107765198,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.9487000107765198,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.04439999908208847,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/intravaginal-ring","display_name":"intravaginal ring","score":0.8830000162124634},{"id":"https://openalex.org/keywords/hiv-pre-exposure-prophylaxis","display_name":"HIV pre-exposure prophylaxis","score":0.9919999837875366},{"id":"https://openalex.org/keywords/tenofovir-disoproxil-fumarate","display_name":"tenofovir disoproxil fumarate","score":0.9789999723434448},{"id":"https://openalex.org/keywords/emtricitabine","display_name":"emtricitabine","score":1.0},{"id":"https://openalex.org/keywords/vaginal-drug-delivery","display_name":"vaginal drug delivery","score":0.6679999828338623},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8180000185966492},{"id":"https://openalex.org/keywords/cervicovaginal-fluid","display_name":"cervicovaginal fluid","score":0.8169999718666077},{"id":"https://openalex.org/keywords/vaginal-microbiota","display_name":"vaginal microbiota","score":0.8050000071525574},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6399999856948853},{"id":"https://openalex.org/keywords/hiv-prevention-in-women","display_name":"HIV prevention in women","score":0.7630000114440918},{"id":"https://openalex.org/keywords/adolescent-girls-and-young-women","display_name":"adolescent girls and young women","score":0.7279999852180481},{"id":"https://openalex.org/keywords/hiv-reverse-transcriptase-inhibition","display_name":"HIV reverse transcriptase inhibition","score":0.5170000195503235},{"id":"https://openalex.org/keywords/optical-coherence-tomography","display_name":"optical coherence tomography","score":0.5479999780654907}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8364999890327454},{"id":"https://openalex.org/C2779778239","wikidata":"https://www.wikidata.org/wiki/Q422604","display_name":"Emtricitabine","level":5,"score":0.8091999888420105},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7476000189781189},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.6948000192642212},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6050999760627747},{"id":"https://openalex.org/C2779755712","wikidata":"https://www.wikidata.org/wiki/Q1927779","display_name":"Vaginal ring","level":5,"score":0.5774000287055969},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5720000267028809},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5715000033378601},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.564300000667572},{"id":"https://openalex.org/C117214928","wikidata":"https://www.wikidata.org/wiki/Q7905570","display_name":"Microbicides for sexually transmitted diseases","level":4,"score":0.5432000160217285},{"id":"https://openalex.org/C2779344132","wikidata":"https://www.wikidata.org/wiki/Q155954","display_name":"Tenofovir","level":3,"score":0.5422000288963318},{"id":"https://openalex.org/C2777744392","wikidata":"https://www.wikidata.org/wiki/Q5880","display_name":"Vagina","level":2,"score":0.4763000011444092},{"id":"https://openalex.org/C197746943","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Microbicide","level":3,"score":0.43700000643730164},{"id":"https://openalex.org/C2779496540","wikidata":"https://www.wikidata.org/wiki/Q7239230","display_name":"Pre-exposure prophylaxis","level":5,"score":0.43050000071525574},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4056999981403351},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4036000072956085},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.38179999589920044},{"id":"https://openalex.org/C97228660","wikidata":"https://www.wikidata.org/wiki/Q7908502","display_name":"Vaginal microbicide","level":5,"score":0.3643999993801117},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.35740000009536743},{"id":"https://openalex.org/C2777351918","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Reverse-transcriptase inhibitor","level":5,"score":0.3310000002384186},{"id":"https://openalex.org/C149151106","wikidata":"https://www.wikidata.org/wiki/Q4677569","display_name":"Active metabolite","level":3,"score":0.32910001277923584},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.31700000166893005},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.31360000371932983},{"id":"https://openalex.org/C2777831542","wikidata":"https://www.wikidata.org/wiki/Q537478","display_name":"Vaginal flora","level":3,"score":0.2578999996185303},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.25760000944137573},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.2500999867916107}],"mesh":[{"descriptor_ui":"D000068679","descriptor_name":"Emtricitabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000068679","descriptor_name":"Emtricitabine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000068679","descriptor_name":"Emtricitabine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000068698","descriptor_name":"Tenofovir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000068698","descriptor_name":"Tenofovir","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000068698","descriptor_name":"Tenofovir","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000282","descriptor_name":"Administration, Intravaginal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003274","descriptor_name":"Contraceptive Devices, Female","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014621","descriptor_name":"Vagina","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065129","descriptor_name":"Pre-Exposure Prophylaxis","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.3389/fcimb.2026.1955105","doi":"https://doi.org/10.3389/fcimb.2026.1955105","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fcimb.2026.1955105","pdf_url":"https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2026.1955105/pdf","source":{"id":"https://openalex.org/S2506667490","display_name":"Frontiers in Cellular and Infection Microbiology","issn_l":"2235-2988","issn":["2235-2988"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Cellular and Infection Microbiology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13680163","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13680163/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13680163/pdf/fcimb-16-1955105.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Cell Infect Microbiol","raw_type":"Text"},{"id":"pmid:42903070","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42903070","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in cellular and infection microbiology","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:doaj.org/article:ee449d0e584d4551b0bfa10079b284b2","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/ee449d0e584d4551b0bfa10079b284b2","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Cellular and Infection Microbiology, Vol 16 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fcimb.2026.1955105","doi":"https://doi.org/10.3389/fcimb.2026.1955105","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fcimb.2026.1955105","pdf_url":"https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2026.1955105/pdf","source":{"id":"https://openalex.org/S2506667490","display_name":"Frontiers in Cellular and Infection Microbiology","issn_l":"2235-2988","issn":["2235-2988"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Cellular and Infection Microbiology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G944092896","display_name":"Systematic Development of Antiretroviral Intravaginal Rings for HIV Prevention","funder_award_id":"U19AI113048","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7220739600.pdf","grobid_xml":"https://content.openalex.org/works/W7220739600.grobid-xml"},"referenced_works_count":52,"referenced_works":["https://openalex.org/W1868667984","https://openalex.org/W1895220657","https://openalex.org/W1934467354","https://openalex.org/W1943068996","https://openalex.org/W1978934985","https://openalex.org/W1989094990","https://openalex.org/W1991862526","https://openalex.org/W1996737119","https://openalex.org/W2006570914","https://openalex.org/W2021794886","https://openalex.org/W2022863478","https://openalex.org/W2025824734","https://openalex.org/W2029667752","https://openalex.org/W2047154690","https://openalex.org/W2056842079","https://openalex.org/W2063191170","https://openalex.org/W2075603925","https://openalex.org/W2077761247","https://openalex.org/W2077902385","https://openalex.org/W2078085043","https://openalex.org/W2082467317","https://openalex.org/W2087692639","https://openalex.org/W2090044939","https://openalex.org/W2095844669","https://openalex.org/W2106585418","https://openalex.org/W2109238714","https://openalex.org/W2121288293","https://openalex.org/W2146634980","https://openalex.org/W2171640664","https://openalex.org/W2290010664","https://openalex.org/W2291994334","https://openalex.org/W2333258704","https://openalex.org/W2416499291","https://openalex.org/W2558446330","https://openalex.org/W2606779843","https://openalex.org/W2619565046","https://openalex.org/W2735458206","https://openalex.org/W2751016010","https://openalex.org/W2799658084","https://openalex.org/W2864614873","https://openalex.org/W2888507442","https://openalex.org/W2894262207","https://openalex.org/W2914488660","https://openalex.org/W2960534569","https://openalex.org/W3127596325","https://openalex.org/W3205544977","https://openalex.org/W4249365836","https://openalex.org/W4388007236","https://openalex.org/W4411928606","https://openalex.org/W4411928610","https://openalex.org/W4413786166","https://openalex.org/W7167616990"],"related_works":["https://openalex.org/W2894262207","https://openalex.org/W2960534569","https://openalex.org/W2888507442","https://openalex.org/W7096195704","https://openalex.org/W4392515843","https://openalex.org/W2333258704","https://openalex.org/W2416706976","https://openalex.org/W2761054444","https://openalex.org/W4380629914","https://openalex.org/W7167616990"],"abstract_inverted_index":{"Introduction":[0],"In":[1,50],"Eastern":[2],"and":[3,14,19,44,73,159,183,224,249,289,321,335],"Southern":[4],"Africa,":[5],"63%":[6],"of":[7,77,102,142,162,190,236,268,274,311,341],"new":[8],"HIV":[9,31,64,275,356],"infections":[10],"occurred":[11],"in":[12,39,89,140,173,195,300,316,327],"women":[13,21,91,111],"girls,":[15],"with":[16,86,229,352],"adolescent":[17],"girls":[18],"young":[20],"representing":[22],"a":[23,61,78,103,119,191],"particularly":[24],"vulnerable":[25],"subpopulation.":[26],"Effective":[27],"vaginal":[28,164,177,213,265,355],"products":[29],"for":[30,63,122,133,272],"prevention":[32],"are":[33,37],"desirable":[34],"because":[35],"they":[36],"underrepresented":[38],"the":[40,71,163,208,212,269,307,338,348],"currently":[41],"approved":[42],"portfolio":[43],"have":[45],"attributes":[46],"motivating":[47],"product":[48,131,147,210],"use.":[49,343],"this":[51],"trial,":[52],"we":[53],"evaluated":[54],"an":[55,114],"innovative":[56],"intravaginal":[57],"ring":[58],"(pod-IVR)":[59],"as":[60],"platform":[62],"pre-exposure":[65],"prophylaxis":[66],"(PrEP).":[67],"Objective":[68],"To":[69],"measure":[70],"safety":[72],"multicompartment":[74],"pharmacokinetics":[75],"(PKs)":[76],"pod-IVR":[79,117,121],"delivering":[80],"tenofovir":[81,222],"disoproxil":[82],"fumarate":[83],"(TDF)":[84],"combined":[85],"emtricitabine":[87],"(FTC)":[88,323],"healthy":[90],"over":[92,337],"28":[93,123,135,339],"days.":[94,136],"Methods":[95],"The":[96,330,344],"Phase":[97],"1":[98],"clinical":[99],"trial":[100,359],"consisted":[101],"randomized":[104],"order,":[105],"controlled,":[106],"double-blinded,":[107],"crossover":[108,132],"design.":[109],"Ten":[110],"received":[112],"either":[113],"active":[115],"TDF-FTC":[116,331],"or":[118,216],"placebo":[120],"days,":[124],"determined":[125],"by":[126,130,155],"1:1":[127],"randomization,":[128],"followed":[129],"another":[134],"Safety":[137],"was":[138,187,204,226],"assessed":[139],"terms":[141],"adverse":[143],"events":[144],"related":[145,196],"to":[146,221],"use,":[148],"colposcopic":[149],"examination,":[150],"cervicovaginal":[151,174],"epithelium":[152],"thickness":[153],"measurement":[154],"optical":[156],"coherence":[157],"tomography,":[158],"culture-independent":[160],"assessment":[161],"microbiome.":[165],"Drug":[166,298],"and/or":[167],"drug":[168],"metabolite":[169],"concentrations":[170,235,267,299],"were":[171,262,305,314,333],"measured":[172],"fluid":[175],"(CVF),":[176],"tissue,":[178,180],"rectal":[179,181,301,317],"fluid,":[182],"plasma.":[184],"Results":[185],"There":[186,202],"no":[188,205],"evidence":[189,206],"statistically":[192],"significant":[193],"difference":[194],"adverse-event":[197],"counts":[198],"between":[199],"study":[200,209],"products.":[201],"also":[203],"suggesting":[207],"altered":[211],"microbiome":[214],"systematically":[215],"reproducibly.":[217],"Systemic":[218],"plasma":[219],"exposure":[220],"(TFV)":[223,320],"FTC":[225,250,290],"low,":[227],"consistent":[228],"topical":[230],"delivery.":[231],"High":[232],"median":[233],"CVF":[234],"TFV":[237,282],"(38.9":[238],"ng":[239,252],"mg":[240,246,253,259,287,295],"-1":[241,247,254,260,288,296],";":[242,255],"135\u00d710":[243],"3":[244,257,285,293],"fmol":[245,258,286,294],")":[248,261],"(239":[251],"966\u00d710":[256],"measured.":[263],"Median":[264],"tissue":[266,302],"anabolites":[270],"responsible":[271],"inhibition":[273],"reverse":[276],"transcriptase":[277],"exceeded":[278],"our":[279],"target":[280,349],"concentrations:":[281],"diphosphate":[283],"0.651\u00d710":[284],"triphosphate":[291],"0.180\u00d710":[292],".":[297],"samples":[303],"generally":[304],"below":[306],"analytical":[308],"lower":[309,325],"limits":[310],"quantification,":[312],"but":[313],"quantifiable":[315],"fluids,":[318],"130":[319],"300":[322],"times":[324],"than":[326],"CVF.":[328],"Conclusions":[329],"pod-IVRs":[332],"safe":[334],"well-tolerated":[336],"days":[340],"consecutive":[342],"PK":[345],"data":[346],"met":[347],"benchmarks":[350],"associated":[351],"protection":[353],"from":[354],"infection.":[357],"Clinical":[358],"registration":[360],"https://clinicaltrials.gov/study/NCT03255915":[361],",":[362],"identifier":[363],"NCT03255915.":[364]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2026-10-07T00:00:00"}